GSK Plc (GSK)
52.40
+0.34
(+0.64%)
USD |
NYSE |
Mar 19, 16:00
52.45
+0.06
(+0.10%)
After-Hours: 20:00
GSK Shareholders Equity (Quarterly) : 22.03B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 48.67B |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 46.60M |
| BioNTech SE | 22.58B |
| Rapt Therapeutics, Inc. (DELISTED) | 151.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.21B |
| Total Liabilities (Quarterly) | 60.75B |
| Debt to Equity Ratio | 1.082 |
| Current Ratio | 0.8186 |
| Net Debt Paydown Yield | -0.47% |